Navigation Links
New drug treatment extends lives of men with prostate cancer
Date:5/26/2011

AURORA, Colo. (May 25, 2011) - A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months. The study in the May 26, 2011 issue of the New England Journal of Medicine was co-authored by Thomas W. Flaig, MD, medical oncologist at the University of Colorado Hospital's Tony Grampsas Urologic Oncology Clinic and assistant professor at the University of Colorado School of Medicine.

"Abiraterone acetate is a new, life-extending pill for the treatment of advanced prostate cancer. Unlike the traditional chemotherapy drugs used in these situations, abiraterone is generally very well tolerated," said Flaig.

The multi-center Phase III clinical trial of 1195 participants looked at the effectiveness of treating patients who had received prior chemotherapy with a combination of abiraterone acetate (ZytigaTM ) and prednisone. When this trial was initiated, there were no treatments that clearly prolonged survival in this late phase of prostate cancer. The patients were randomized to receive abiraterone acetate plus prednisone or a placebo plus prednisone each day. Treatment continued until the cancer progressed, there were unfavorable reactions, a new treatment was initiated or the patient withdrew from the trial.

The study shows participants taking abiraterone acetate lived about four months longer than participants taking the placebo. In addition, more patients receiving abiraterone acetate experienced a significant drop in the PSA blood level than those on the placebo.

"The survival benefit observed in this study is especially notable, since this was seen in the most advanced cases of prostate cancer," said Flaig. "Other studies are being done to examine the benefit of using abiraterone acetate earlier in the disease process, whe
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
720-848-7852
University of Colorado Denver
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Unique nerve-stimulation treatment proves effective against drug-resistant epilepsy
2. Clinical trials for new Alzheimers disease treatment to be awarded European Commission €6m funding
3. US study shows that tofacitinib is an efficacious treatment for active RA
4. Research suggests that lipofilling may be safe during conservation treatment for breast cancer
5. New study aims to improve long-term treatment for patients with bipolar disorder
6. PET scans predict effectiveness of treatment for multidrug-resistant tuberculosis in HIV patients
7. IUPUI study first to look at early treatment of depression to reduce heart disease risk
8. Mount Sinai researchers discover possible new target for sarcoma treatment and prevention
9. Quicker detection and treatment of severe sepsis
10. Substantial recovery rate with placebo effect in headache treatment
11. Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed a lawsuit ... fell ill with a hepatitis A infection after eating ... The complaint was filed in Snohomish County Superior Court ... firm that has filed 14 previous lawsuits against ... Brothers consumed “Townsend Farms Organic Antioxidant Blend” on multiple ...
(Date:6/18/2013)... Horsham, PA (PRWEB) June 18, 2013 Senior ... in Boston on June 25 to discuss—for the first time ... agencies in getting drugs through the regulatory process in a ... of drug evaluation will share respective best practices and processes ... Across the Strait panel at the DIA 2013 ...
(Date:6/18/2013)... Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at ... on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. ... Verano and will go to the lucky golfer at the ... , The MFHS golf tournament is open to all interested ... crew team for 18 holes. The fee is $125 per ...
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... The July 2013 issue of Marie Claire ... Beach Ready,” offers a list of home and doctor’s office ... a bathing suit this summer. The list includes treatment options ... smoothing cellulite , and more. (go to goo.gl/aIe4J). , “It’s ... Epione Beverly Hills, “though I would say some of the ...
Breaking Medicine News(10 mins):Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2
... with Attention Deficit Hyperactivity Disorder - ADHD - ... with decision-making, thinking and planning. The abnormality was ... researchers to look at the brains of children ... of Child Psychiatry at the Medical Research Council, ...
... and Drug Administration agreed that an ingredient commonly used ... recommend further review by the FDA. ,The FDA ... five-year study by Yale University researchers that found phenyl-propanolamine ... the risk of stroke in some users. PPA helps ...
... a degenerative brain disease that usually begins gradually, ... familiar tasks. The disease eventually leads// to confusion, ... becomes more difficult as the disease progresses, leaving ... or follow directions. Eventually, most people with Alzheimer’s ...
... way to predict when somebody is likely to have ... occur suddenly and without warning and can lead to ... de la Pitie-Salpetriere, Paris, believe ,it may be possible ... an electroencephalogram ,(EEG). ,An ECG records electrical activity ...
... may allow treatment at a later stage than other ... the market for a decade in Germany// and was ... of the Food and Drug Administration. ... approved Alzheimer's drugs, such as Aricept, that have been ...
... Women are more prone to get depression during their pregnancy ... for depression was 32 weeks// into pregnancy, close to birth. ... a rise in stress hormones could lead to low birth ... the Avon area, whose babies were due between April 1 ...
Cached Medicine News:
(Date:6/18/2013)... Australia And EMERYVILLE, Calif. ... Pharmaceuticals, Inc. presented final results today from a ... extended release) capsules demonstrating a statistically significant improvement ... from baseline at week 8 versus placebo in ... Adamas, investigational extended-release formulation of amantadine intended for ...
(Date:6/18/2013)... BASKING RIDGE, N.J. , June 18, 2013 /PRNewswire/ ... Adrian Peterson and professional family expert ... are partnering with Mylan Specialty L.P., the fully integrated ... MYL ), to raise awareness of this significant health ... of the U.S. Food and Drug Administration (FDA) approval ...
(Date:6/18/2013)... 18, 2013   Polymer Technology Systems, Inc. ... Health Group to integrate the CardioChek ® ... administered by health systems across the country. The ... and distributed through Hanson Medical Systems , ... cholesterol, LDL cholesterol, triglycerides, and glucose. ...
Breaking Medicine Technology:Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
... , CHADDS FORD, Pa. , Aug. 6 Endo Pharmaceuticals ... at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on ... executive vice president and chief financial officer of Endo, will review the company,s ... , ...
... ,, WEIFANG, Shandong , ... Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... , Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its,operating ... with Jiangsu Zongheng,Drying Equipment Co., Ltd. ("Jiangsu Zongheng") to ...
Cached Medicine Technology:Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 2Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 2Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 3Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 4
... designed specifically for the Palm Organizers ... ward rounds. It is intended to ... consultations that are requested by the ... Ward round examinations and to record ...
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products: